Neurocognitive Decline Study

Exploring the effects of statins on neurocognitive decline in the elderly

Neurocognitive Decline Study

Exploring the effects of statins on neurocognitive decline in the elderly

Neurocognitive Decline Study: PREVENTABLE Trial

Trial Overview

Hawthorne Effect is thrilled to have been awarded the opportunity to collaborate in support of the PREVENTABLE Trial – a landmark clinical trial conducted in partnership with Duke Clinical Research Institute, Wake Forest University, PCORI, the VA and the National Institutes of Health. This is a world-class team of geriatric and cardiology investigators posing an important question regarding medical management in the elderly population.

This study explores the effect of use of statins on neurocognitive decline in the elderly. Hero visits will make it easier for patients to participate from the comfort of their homes.

Trial Requirements

  1. Blood draw skills (Phlebotomist, RN, PA, EMT, etc.)
  2. Conduct of a functional assessment called the SPPB (training will be offered).

What To Expect

  1. HERO informational ZOOM

  2. Complete onboarding and study certification on Hawthorne Platform with Duke

  3. Receive study sign on gift and HERO bag with PPE

  4. When accepting a visit, flow is as follows:

    • Blood draw kits are picked up at the research site,
    • HERO goes to patient home to collects samples
    • Samples need to be placed in pre-packaged specimen bags and dropped off back at the clinical site within 4
      hours of the visit.
  5. Competitive pay for each visit and up to 5 visits per week

Active Trials

Scroll to Top